Patents by Inventor Faidra STAVROPOULOU

Faidra STAVROPOULOU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IDENTIFICATION OF CANDIDATE SIGNS INDICATIVE OF AN NTRK ONCOGENIC FUSION
    Publication number: 20220223261
    Abstract: The present invention relates to the identification of one or more candidate signs indicative of an NTRK oncogenic fusion within patient data. Subject matter of the present invention are a computer-implemented method, a system, and a non-transitory computer-readable storage medium for determining a probability value from patient data associated with a subject patient, the probability value indicating the probability of the subject patient suffering from cancer caused by a mutation of a neurotrophic receptor tyrosine kinase (NTRK) gene.
    Type: Application
    Filed: April 28, 2020
    Publication date: July 14, 2022
    Applicant: Bayer Consumer Care AG
    Inventors: Arndt SCHMITZ, Eren Metin ELCI, Faidra STAVROPOULOU, Mikhail KACHALA, Antti KARLSSON, Mikko TUKIAINEN